NM_001099922.3:c.3039A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001099922.3(ALG13):​c.3039A>G​(p.Val1013Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000635 in 1,207,045 control chromosomes in the GnomAD database, including 5 homozygotes. There are 208 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 3 hom., 117 hem., cov: 22)
Exomes 𝑓: 0.00032 ( 2 hom. 91 hem. )

Consequence

ALG13
NM_001099922.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0330

Publications

0 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant X-111757653-A-G is Benign according to our data. Variant chrX-111757653-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 383513.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.033 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0037 (410/110938) while in subpopulation AFR AF = 0.0128 (391/30526). AF 95% confidence interval is 0.0118. There are 3 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001099922.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
NM_001099922.3
MANE Select
c.3039A>Gp.Val1013Val
synonymous
Exon 26 of 27NP_001093392.1Q9NP73-1
ALG13
NM_001257231.2
c.2805A>Gp.Val935Val
synonymous
Exon 26 of 27NP_001244160.1Q9NP73-3
ALG13
NM_001324292.2
c.2802A>Gp.Val934Val
synonymous
Exon 25 of 26NP_001311221.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG13
ENST00000394780.8
TSL:2 MANE Select
c.3039A>Gp.Val1013Val
synonymous
Exon 26 of 27ENSP00000378260.3Q9NP73-1
ALG13
ENST00000927365.1
c.3015A>Gp.Val1005Val
synonymous
Exon 26 of 27ENSP00000597424.1
ALG13
ENST00000927366.1
c.2865A>Gp.Val955Val
synonymous
Exon 24 of 25ENSP00000597425.1

Frequencies

GnomAD3 genomes
AF:
0.00362
AC:
401
AN:
110888
Hom.:
3
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000777
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000384
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000943
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.000953
AC:
169
AN:
177262
AF XY:
0.000598
show subpopulations
Gnomad AFR exome
AF:
0.0131
Gnomad AMR exome
AF:
0.000295
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000128
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000325
AC:
356
AN:
1096107
Hom.:
2
Cov.:
30
AF XY:
0.000252
AC XY:
91
AN XY:
361697
show subpopulations
African (AFR)
AF:
0.0113
AC:
298
AN:
26325
American (AMR)
AF:
0.000370
AC:
13
AN:
35097
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19356
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30142
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
53938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40499
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4127
European-Non Finnish (NFE)
AF:
0.00000952
AC:
8
AN:
840607
Other (OTH)
AF:
0.000782
AC:
36
AN:
46016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00370
AC:
410
AN:
110938
Hom.:
3
Cov.:
22
AF XY:
0.00353
AC XY:
117
AN XY:
33172
show subpopulations
African (AFR)
AF:
0.0128
AC:
391
AN:
30526
American (AMR)
AF:
0.000776
AC:
8
AN:
10303
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3520
South Asian (SAS)
AF:
0.000385
AC:
1
AN:
2597
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5949
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.0000943
AC:
5
AN:
52995
Other (OTH)
AF:
0.00332
AC:
5
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00143
Hom.:
8
Bravo
AF:
0.00390

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Developmental and epileptic encephalopathy, 36 (3)
-
-
2
not specified (2)
-
-
1
ALG13-related disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.9
DANN
Benign
0.74
PhyloP100
-0.033
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183032531; hg19: chrX-111000881; API